TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib
Sign Up to like & getrecommendations! Published in 2018 at "European Radiology"
DOI: 10.1007/s00330-018-5692-8
Abstract: ObjectivesTo date, there is no approved second-line treatment for patients dismissing sorafenib or ineligible for this treatment, so it would be useful to find an effective alternative treatment option. The aim of our study was… read more here.
Keywords: dsm tace; tace; hcc; treatment ... See more keywords